🔊 @Opin_Health, Opyl's health #research recruitment specialists, are delighted to announce the release of a new, free #report: Outlook for Australia & New Zealand Clinical Trials 2024! Download it here: https://t.co/Jt5Ze1tbuZ
There are so many ways in which AI is impacting and improving clinical trial inputs and outcomes. From patient identification and selection @Opin_Health through to XAI #clinicaltrial design @TrialKeyAI - great article from SaxonAI https://t.co/yRdsiuwhLi
Opin is a global website designed to help people find and take part in health and medical research. Visit https://t.co/0s7nDc2qQI to find research studies near you.
#ClinicalTrials#MedicalResearch
See how we're applying #AI to improve #clinicaltrial design, ensuring more discoveries make it to the clinic. @OpylAI CEO @StartupShelley will showcase @TrialKeyAI for the 1st time, demonstrating how we're saving time & billions of $$ @futuremetaconf https://t.co/KNfLqpraPc
#PodcastAlert The last in our series celebrating #ClinicalTrialsDay#CTD2023 International Clinical Trials Day: The evolving roles of patient advocacy and health research, with James Stewart of @PancareAus https://t.co/fwREIw2gjK
📢 Exciting news! @OpylAI CEO Michelle Gallaher will share insights on #ClinicalTrial data collection & evidence generation, regulatory considerations, & clinical trial efficiency at #AusMedTech tomorrow. Join her session in Room L2 at the Adelaide Convention Centre at 4:15 pm.
Minister for Health and Medical Research @MaryAnneThomas highlight the leadership and value of investing in #clinicaltrials in Victoria. Our CEO @StartupShelley is speaking on the panel at @AmChamAU lunch today about @Opin_Health and how AI is improving trials 🙌🏻 $OPL
$OPL announces the appointment of Dr Hugo Stephenson as an advisor. Dr Stephenson brings global experience in commercialising clinical trial data management platforms and trial efficiency solutions.https://t.co/fUVEI3LDLv
Our collaborator @karinv delivered a fantastic foundation presentation on #ChatGPT demystifying and clarifying language models. We are using ChatGPT with @Opin_Health making #clinicaltrials more accessible and equitable https://t.co/UVKPKlfOpb
Curious about how #AI is impacting #clinicaltrials? Come over and listen to the chat between our CEO @StartupShelley and CTO Damon Rasheed in our first podcast of the OpylPod series. 22 minutes https://t.co/B5ZuMLaxPU
Hearty congratulations to @eltoroquerie winning the Research Award for Impact and Collaboration last night at @RMIT for work with @OpylAI on #TrialKey - it’s has been an incredible collaboration and a game changer for #TrialKey 🥂🥂🥂🥂🥂 #TeamOpyl $OPL
Podcast alert: Our first $OPL podcast dropped today, featuring CEO @StartupShelley & CTO Damon Rasheed discussing TrialKey - our novel #AI approach to improving #clincialtrial protocols, setting trials and studies up for success. The next one is on GPT3 https://t.co/ShBXwbrgSF